Literature DB >> 16170002

Diurnal variations in the plasma concentration of parathyroid hormone in dogs.

I López1, E Aguilera-Tejero, J C Estepa, S Bas, R Mayer-Valor, A Jiménez, M Rodríguez.   

Abstract

The plasma concentrations of parathyroid hormone (PTH), ionised calcium (Ca(2+)), total calcium, albumin and inorganic phosphorus, and the pH were measured in blood samples obtained from nine dogs during a period of 26 hours. The plasma pth levels fluctuated slightly during the day, by about 20 pg/ml, but there was a distinct peak (42.8 [8.8] pg/ml) at 07.00. Plasma Ca(2+) showed a diurnal pattern in which two peaks (increases of 0.03 mmol/l) were observed at 05.00 and 17.00, and the plasma concentration of inorganic phosphorus showed a similar pattern. There were no diurnal changes in total calcium or albumin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16170002     DOI: 10.1136/vr.157.12.344

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

1.  Serum Biochemical Phenotypes in the Domestic Dog.

Authors:  Yu-Mei Chang; Erin Hadox; Balazs Szladovits; Oliver A Garden
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

2.  Association of Vitamin D Metabolites with Parathyroid Hormone, Fibroblast Growth Factor-23, Calcium, and Phosphorus in Dogs with Various Stages of Chronic Kidney Disease.

Authors:  V J Parker; L M Harjes; K Dembek; G S Young; D J Chew; R E Toribio
Journal:  J Vet Intern Med       Date:  2017-02-10       Impact factor: 3.333

3.  Fibroblast Growth Factor-23 Concentration in Dogs with Chronic Kidney Disease.

Authors:  L M Harjes; V J Parker; K Dembek; G S Young; L H Giovaninni; M M Kogika; D J Chew; R E Toribio
Journal:  J Vet Intern Med       Date:  2017-04-17       Impact factor: 3.333

4.  Single oral dose safety of D-allulose in dogs.

Authors:  Naohito Nishii; Toru Nomizo; Satoshi Takashima; Tatsuya Matsubara; Masaaki Tokuda; Hitoshi Kitagawa
Journal:  J Vet Med Sci       Date:  2016-03-14       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.